Sanofi Shares Rebound Nearly 3%, Posting One of the Strongest Gains in the CAC 40
The pharmaceutical company marks one of the sharpest rebounds in the CAC 40 mid-morning, after a decline phase that had driven the stock below its moving averages. The stock reconnects with an initial technical reference point, as the Paris index moves close to equilibrium.
A Rebound of 2.71% Brings the Stock Back to Contact with its 20-Day Moving Average at €75.10
Sanofi stock gains 2.71% to €75.03, up from €73.05 at the previous close, ranking it among the strongest rises in the CAC 40. The stock returns to contact with its 20-day moving average located at €75.10, now only 0.09% away. However, it remains below its 50-day moving average at €75.61 (a gap of -0.77%) and significantly under its 200-day moving average at €80.57 (-6.88%), reflecting a still deteriorated long-term trend after a decline of more than 10% over three months. The RSI at 52 moves out of the neutral zone upwards, while the MACD remains slightly negative but sees its histogram move back into positive territory, consistent with today's rebound. The support at €72.49, tested at the end of June after breaking the €72.72 threshold mentioned in a brief from June 22, has so far held firm. The rebound occurs in a non-directional Paris market (CAC 40 at -0.19%), but supported by cyclical and defensive stocks, with ArcelorMittal and Airbus leading. Over a week, the performance is barely positive (+1.02%), highlighting that today's movement mainly corrects a recent phase of weakness.
